Parathyroid Carcinoma Presenting as Recurrent Primary Hyperparathyroidism and Neck Mass: A Case Report.
Case report
endocrine neoplasm
hypercalcaemia
neck dissection
neck mass
parathyroid carcinoma
primary hyperparathyroidism
radiotherapy
Journal
TouchREVIEWS in endocrinology
ISSN: 2752-5457
Titre abrégé: touchREV Endocrinol
Pays: England
ID NLM: 101779126
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
05
05
2023
accepted:
31
05
2023
medline:
4
12
2023
pubmed:
4
12
2023
entrez:
4
12
2023
Statut:
ppublish
Résumé
Parathyroid carcinoma is a rare endocrine neoplasm that accounts for <1% of cases of primary hyperparathyroidism. The management of parathyroid carcinoma is a challenge due to the high rate of local recurrence of the tumour. We report the case of a middle-aged north Indian woman who presented with recurrent primary hyperparathyroidism due to parathyroid carcinoma. She presented with a recurrent palpable hard neck mass and underwent radical dissection of the neck six times. At the time of writing this report, she was referred for external beam radiotherapy to the neck. Parathyroid carcinoma is a rare malignancy with an indolent but tenacious course. Complete resection at the time of initial surgery determines the prognosis of the neoplasm. Chemotherapy and radiotherapy are usually ineffective. Hypercalcaemia needs to be aggressively managed. A multidisciplinary team is required to effectively manage parathyroid carcinoma.
Identifiants
pubmed: 38046185
doi: 10.17925/EE.2023.19.2.6
pmc: PMC10688562
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
80-85Informations de copyright
© Touch Medical Media 2023.
Déclaration de conflit d'intérêts
Disclosures: Hiya Boro, Harish Sharma, Deepak Mittal, Mohit Pareek, Shilpa Chugh, Mohar Singh Jakhar, Neeraj Nagar, Lovekesh Bhatia, Sanjay Saini, Vashishth Joshi, Sahil Vaid, Velmurugan Mannar, Lakshmi Nagendra, Mazhar Dalvi and Vikash Bundela have no financial or non-financial relationships or activities to declare in relation to this article.
Références
Am J Med. 1990 Sep;89(3):327-34
pubmed: 2393037
Intern Med. 1994 Nov;33(11):697-702
pubmed: 7849385
J Clin Endocrinol Metab. 2001 Feb;86(2):485-93
pubmed: 11157996
Curr Treat Options Oncol. 2012 Mar;13(1):11-23
pubmed: 22327883
N Am J Med Sci. 2015 Nov;7(11):483-93
pubmed: 26713296
J Clin Endocrinol Metab. 2007 Oct;92(10):3803-8
pubmed: 17666472
Head Neck. 2004 Aug;26(8):716-26
pubmed: 15287039
Front Oncol. 2022 Sep 26;12:997009
pubmed: 36226055
Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):569-72
pubmed: 9635703
J Bone Miner Res. 2008 Dec;23(12):1869-80
pubmed: 19016595
Cancers (Basel). 2022 Mar 10;14(6):
pubmed: 35326576
J Clin Endocrinol Metab. 2023 Feb 15;108(3):585-591
pubmed: 36545700
Medicine (Baltimore). 1992 Jul;71(4):197-205
pubmed: 1518393
J Clin Endocrinol Metab. 2011 Dec;96(12):3679-86
pubmed: 21937626
Endocr Pathol. 2022 Mar;33(1):64-89
pubmed: 35175514
Bone. 2020 Aug;137:115390
pubmed: 32353565
J ASEAN Fed Endocr Soc. 2019;34(2):229-232
pubmed: 33442162
Arch Surg. 2001 Aug;136(8):878-85
pubmed: 11485522
Front Endocrinol (Lausanne). 2022 Jan 31;12:794988
pubmed: 35173680
J Clin Endocrinol Metab. 2004 Jul;89(7):3413-20
pubmed: 15240624
J Intern Med. 2016 Dec;280(6):574-583
pubmed: 27306766
Br Med J. 1973 Jan 6;1(5844):27-8
pubmed: 4683634
Am Surg. 1985 Jul;51(7):372-4
pubmed: 4014880
Arch Intern Med. 1984 Feb;144(2):399-400
pubmed: 6696578
Clin Endocrinol (Oxf). 1998 Jan;48(1):67-72
pubmed: 9509070
Endocr Pract. 2015 May;21(5):468-73
pubmed: 25667369
Surgery. 1987 Jun;101(6):649-60
pubmed: 3589961
Endocrinol Diabetes Metab Case Rep. 2014;2014:140056
pubmed: 25298882
Endocrine. 2020 Jan;67(1):204-208
pubmed: 31782130